Buratuss-SR

Clinical Trials

Clinical trials have demonstrated Butamirate Citrate's efficacy in reducing cough frequency and intensity, with good tolerability. Studies support its central antitussive action and favorable safety profile.

Lab Monitoring

• No specific routine lab monitoring required.

Doctor Notes

• Advise patients to seek medical attention if cough persists or worsens.
• Not suitable for productive cough where mucus clearance is important.
• Exercise caution in patients with hepatic impairment.

Patient Guidelines

• Do not exceed the recommended dose.
• Inform your doctor if cough persists for more than 7 days or worsens.
• Avoid driving or operating heavy machinery if you experience dizziness or drowsiness.

Missed Dose Advice

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not double the dose to catch up.

Driving Precautions

Butamirate may cause dizziness or drowsiness. Patients should be cautioned about engaging in activities requiring mental alertness, such as driving or operating machinery, until they know how the drug affects them.

Lifestyle Advice

• Stay hydrated by drinking plenty of fluids.
• Avoid irritants like smoke and dust.
• Maintain a healthy lifestyle.